378 related articles for article (PubMed ID: 32253071)
1. Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
Donders GG; Grinceviciene S; Ruban K; Bellen G
Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115024. PubMed ID: 32253071
[TBL] [Abstract][Full Text] [Related]
2. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
3. Is multiple-site colonization with Candida spp. related to inadequate response to individualized fluconazole maintenance therapy in women with recurrent Candida vulvovaginitis?
Donders GGG; Grinceviciene S; Bellen G; Ruban K
Diagn Microbiol Infect Dis; 2018 Nov; 92(3):226-229. PubMed ID: 30293562
[TBL] [Abstract][Full Text] [Related]
4. Sexual behaviour and extra-genital colonisation in women treated for recurrent Candida vulvo-vaginitis.
Grinceviciene S; Ruban K; Bellen G; Donders GGG
Mycoses; 2018 Nov; 61(11):857-860. PubMed ID: 29998617
[TBL] [Abstract][Full Text] [Related]
5. The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis.
Donders G; Bellen G; Ausma J; Verguts L; Vaneldere J; Hinoul P; Borgers M; Janssens D
Eur J Clin Microbiol Infect Dis; 2011 Jan; 30(1):59-63. PubMed ID: 20878199
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women.
Gunther LS; Martins HP; Gimenes F; Abreu AL; Consolaro ME; Svidzinski TI
Sao Paulo Med J; 2014; 132(2):116-20. PubMed ID: 24714993
[TBL] [Abstract][Full Text] [Related]
7. Non-response to fluconazole maintenance treatment (ReCiDiF regimen) for recurrent vulvovaginal candidosis is not related to impaired glucose metabolism.
Grinceviciene S; Bellen G; Ruban K; Donders G
Mycoses; 2017 Aug; 60(8):546-551. PubMed ID: 28429840
[TBL] [Abstract][Full Text] [Related]
8. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).
Donders G; Bellen G; Byttebier G; Verguts L; Hinoul P; Walckiers R; Stalpaert M; Vereecken A; Van Eldere J
Am J Obstet Gynecol; 2008 Dec; 199(6):613.e1-9. PubMed ID: 18976735
[TBL] [Abstract][Full Text] [Related]
9. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
Mendling W; Brasch J; ; ; ;
Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
[TBL] [Abstract][Full Text] [Related]
10. Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review.
Bradfield Strydom M; Khan S; Walpola RL; Ware RS; Tiralongo E
J Med Microbiol; 2023 May; 72(5):. PubMed ID: 37171871
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
Pekhlivanov B; Amaliev I; Ivancheva Kh; Zisova L
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():25-7. PubMed ID: 16028400
[TBL] [Abstract][Full Text] [Related]
12. Abnormal vaginal microbioma is associated with severity of localized provoked vulvodynia. Role of aerobic vaginitis and Candida in the pathogenesis of vulvodynia.
Donders GGG; Bellen G; Ruban KS
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1679-1685. PubMed ID: 29934834
[TBL] [Abstract][Full Text] [Related]
13. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
Fan S; Liu X; Wu C; Xu L; Li J
Mycopathologia; 2015 Feb; 179(1-2):95-101. PubMed ID: 25416649
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term influence of the levonorgestrel-releasing intrauterine system (Mirena®) on vaginal microbiota and Candida.
Donders GGG; Bellen G; Ruban K; Van Bulck B
J Med Microbiol; 2018 Mar; 67(3):308-313. PubMed ID: 29458551
[TBL] [Abstract][Full Text] [Related]
15. [Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J. Muñiz Infectious Diseases Hospital].
Buscemi L; Arechavala A; Negroni R
Rev Iberoam Micol; 2004 Dec; 21(4):177-81. PubMed ID: 15709796
[TBL] [Abstract][Full Text] [Related]
16. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
[TBL] [Abstract][Full Text] [Related]
17. Recurrent vulvovaginal candidiasis.
Sobel JD
Am J Obstet Gynecol; 2016 Jan; 214(1):15-21. PubMed ID: 26164695
[TBL] [Abstract][Full Text] [Related]
18. Management of recurrent vulvo-vaginal candidosis as a chronic illness.
Donders GG; Bellen G; Mendling W
Gynecol Obstet Invest; 2010; 70(4):306-21. PubMed ID: 21051852
[TBL] [Abstract][Full Text] [Related]
19. Is non-response to fluconazole maintenance therapy for recurrent Candida vaginitis related to sensitization to atopic reactions?
Donders GGG; Grinceviciene S; Bellen G; Jaeger M; Ten Oever J; Netea MG
Am J Reprod Immunol; 2018 Apr; 79(4):e12811. PubMed ID: 29469170
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes of Women With Recurrent Vulvovaginal Candidiasis After a Course of Maintenance Antifungal Therapy.
Crouss T; Sobel JD; Smith K; Nyirjesy P
J Low Genit Tract Dis; 2018 Oct; 22(4):382-386. PubMed ID: 29975334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
